ISPOR 2026
Sunday, May 17 - Wednesday, May 20
-
APPLYING ARTIFICIAL INTELLIGENCE TO REAL-WORLD DATA IN NSCLC - TRANSPARENT AND REPRODUCIBLE METHODS FOR PRECISION EVIDENCE
Mar 18, 2026, 21:38 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
A FRAMEWORK FOR INCORPORATING DISTANCE-TO-CARE METRICS IN CANCER OUTCOMES RESEARCH: EXPLORATORY INSIGHTS USING REAL-WORLD DATA FROM A NETWORK OF COMMUNITY PRACTICES
Mar 18, 2026, 21:38 PM -
USING AI TO MAP HEOR EVIDENCE GAPS: FINDINGS FROM A LARGE-SCALE LLM-BASED CLASSIFICATION ANALYSIS
Mar 18, 2026, 21:38 PM -
SHIFTING THE CURVE: VALUING HEALTHCARE UTILIZATION ACROSS PRECLINICAL AND SYMPTOMATIC ALZHEIMER’S DISEASE
Mar 18, 2026, 21:38 PM -
A POPULATION-BASED EPIDEMIOLOGICAL ANALYSIS WITH PROJECTIONS OF FETAL AND NEONATAL TRANSIENT METABOLIC DISORDERS IN HUNGARY
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH TIME TO TREATMENT INITIATION FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS IN AN ACADEMIC MEDICAL SYSTEM
Mar 18, 2026, 21:38 PM -
SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Mar 18, 2026, 21:38 PM -
MANAGING LIMITATIONS OF NET PRICE ESTIMATES AT LAUNCH
Mar 18, 2026, 21:38 PM -
ARTIFICIAL INTELLIGENCE-DRIVEN CLINICAL DRUG REPORT GENERATION
Mar 18, 2026, 21:38 PM -
DESCRIPTION OF THE CHARACTERISTICS AND BURDEN OF NEUROFIBROMATOSIS TYPE 1 WITH PLEXIFORM NEUROFIBROMA IN A SAMPLE OF ADULT PATIENTS IN THE USA: RESULTS FROM A REAL-WORLD SURVEY
Mar 18, 2026, 21:38 PM -
PERFORMANCE OF AI METHODS FOR TITLE/ABSTRACT SCREENING: COMPARING CRITERIA-BASED AND ADVANCEMENT PROBABILITY-BASED SCREENING APPROACHES
Mar 18, 2026, 21:38 PM -
A STRUCTURED FRAMEWORK FOR CATEGORISING UNMET NEED IN HTA: APPLICATION TO SOLID TUMOR ASSESSMENTS ACROSS EIGHT OECD COUNTRIES
Mar 18, 2026, 21:38 PM -
A NEXT-GENERATION FRAMEWORK FOR AI-AUGMENTED, SUBMISSION-GRADE LITERATURE REVIEWS: A MULTI-PROJECT ANALYSIS OF SPEED, ACCURACY, AND WORKFLOW EVOLUTION
Mar 18, 2026, 21:38 PM -
EXPLORING THE POTENTIAL IMPACT OF THE INFLATION REDUCTION ACT’S PART D REDESIGN ON FORMULARY COVERAGE?IN COMPETITIVE CLASSES: 2024-2026
Mar 18, 2026, 21:38 PM -
REAL-WORLD EVIDENCE TO SUPPORT HEALTH TECHNOLOGY ASSESSMENT AND PAYER DECISION MAKING: A REVIEW OF POLICY AND GUIDANCE ACROSS EUROPE, CANADA, AND THE UNITED STATES
Mar 18, 2026, 21:38 PM -
SUCCESSFUL USES OF REAL-WORLD EVIDENCE IN FDA LABEL UPDATES: A DESCRIPTIVE ANALYSIS OF REGULATORY TRENDS
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF EARLY PREGNANCY IDENTIFICATION AND VIRTUAL GAP CLOSURE ON HEDIS METRICS
Mar 18, 2026, 21:38 PM -
DRIVERS OF MOBILE PATIENT PORTAL APP USE: INSIGHTS FOR IMPLEMENTATION AND VALUE-BASED DECISION-MAKING
Mar 18, 2026, 21:38 PM -
COMPARING HEALTH, HEALTH AND WELLBEING (HWB), AND QUALITY OF LIFE (QOL) VISUAL ANALOGUE SCALE (VAS) CONSTRUCTS WITH THE EQ-HWB-9 IN THE UNITED STATES (US), UNITED KINGDOM (UK), AND GERMANY
Mar 18, 2026, 21:38 PM